HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-014-1900-3.pdf
Reference55 articles.
1. American Cancer Society (2011) Global cancer facts and figures, 2nd edn. American Cancer Society, Atlanta
2. Bang Y, Chung H, Xu J et al (2009) Pathological features of advanced gastric cancer (GC): relationship to human epidermal growth factor receptor 2 (HER2) positivity in the global screening programme of the ToGA trial. J Clin Oncol 27:15s (suppl; abstr 4556)
3. Bang YJ, van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2 positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697
4. Bhargava R, Lal P, Chen B (2005) Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low level amplification: does it measure up to fluorescence in situ hybridization? Am J Clin Pathol 123:237–243
5. Bokemeyer C, Bondarenko I, Hartmann JT et al (2011) Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Ann Oncol 22:1535–1546
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors;npj Precision Oncology;2024-09-12
2. Response Evaluation Criteria in Gastrointestinal and Abdominal Cancers: Which to Use and How to Measure;RadioGraphics;2024-05-01
3. Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma;Cureus;2023-09-21
4. HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma;Virchows Archiv;2023-09-07
5. Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks;British Journal of Cancer;2023-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3